Tobacco Use Cessation Clinical Trial
Official title:
An Evidence Based Smoking Cessation Program for Persons Living With HIV/AIDS
The goal of this research study is to compare 2 different phone-based programs for quitting smoking for people with HIV/AIDS.
If participant agrees to take part in this study, the following will be done at the first
visit (called the Baseline Visit):
- The study staff will give participant advice about quitting smoking. Participant will
then set a quit date, after which they will plan to not smoke anymore.
- Participant will receive a 10-week supply of nicotine patches and instructions on how
to use them.
- Participant will complete questionnaires on a laptop computer about their smoking
habits, how much tobacco they use, how many times they have tried to quit, how ready
they are to quit, and how dependent they are on nicotine. The questionnaires will take
about 30 minutes to complete.
Participant will then be assigned to 1 of 2 study groups. Participant will have a 1 in 5
(20%) chance of being assigned to Group 1, and a 4 in 5 (80%) chance of being assigned to
Group 2.
If participant is in Group 1:
- Participant will receive a telephone number to a hotline for them to use to call and
talk to someone about quitting. Participant can call the hotline anytime they need
support in their effort to quit smoking.
- Participant will also receive 11 phone calls from the study staff over a 6-month
period. During each call, participant will be given support to help them quit. Each
call will last about 15 minutes.
If participant is in Group 2:
- Participant will receive text messages for support about quitting smoking. In the first
week, participant will get about 20 text messages. Each week, participant will receive
fewer text messages, until they get 1 message per week by week 4. Participant will then
get 1 message each week after that through month 6.
- Participant will also receive another text message 1 time each week from the study
staff asking if they have smoked within the past 24 hours. Participant will be asked to
respond to this text message either by sending a text back to the study staff or
calling the study staff. If the study staff does not receive participant's response
they may receive a phone call from the staff asking about their smoking status over the
past 24 hours.
Follow-Up Visits (Both Groups):
Three (3) and 6 months after the Baseline Visit, you will complete questionnaires on a
laptop computer and participant will be asked for more information about their smoking
status. At this visit, participant will also be asked to blow into a cardboard tube to check
for byproducts of smoking. These visits will last about 20 minutes each.
Length of Study:
Participant will be on study for about 6 months.
This is an investigational study.
Up to 1000 patients will take part in this study. All will be enrolled at Legacy Community
Health Services Clinic.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT06021652 -
Feasibility, Adoption and Efficacy of A Virtual Reality Smoking Cessation Program for Patients Undergoing Lung Cancer Screening
|
N/A | |
Completed |
NCT02735382 -
EHR-Based and Fax-Based Referral to a Tobacco Quitline: A Comparative Study
|
N/A | |
Completed |
NCT02557919 -
Families Reduce Exposure to Smoke at Home
|
N/A | |
Completed |
NCT01570595 -
Positively Smoke Free on the Web (PSFW) for Smokers Living With HIV
|
Phase 1/Phase 2 | |
Completed |
NCT00786149 -
Improving Varenicline Adherence and Outcomes in Homeless Smokers
|
Phase 3 | |
Completed |
NCT00387946 -
Efficacy and Safety of Dianicline Treatment as an Aid to Smoking Cessation in Cigarette Smokers (AMERIDIAN)
|
Phase 3 | |
Completed |
NCT00218452 -
Smoking Cessation for Young Adults Who Binge Drink - 1
|
Phase 0 | |
Completed |
NCT00124683 -
Treating Nicotine Dependence in Schizophrenic Individuals: Effectiveness of Bupropion - 1
|
Phase 2 | |
Recruiting |
NCT04610931 -
Study of the Effectiveness of a Virtual Reality Treatment in the Management of Smoking Cessation
|
N/A | |
Enrolling by invitation |
NCT06042361 -
Enhancing Equity in Smoke-free Housing
|
N/A | |
Recruiting |
NCT04994444 -
Preloading With Nicotine Replacement Therapy in HIV-positive Smokers to Improve Self-Efficacy and Quit Attempts
|
Phase 2/Phase 3 | |
Recruiting |
NCT04827420 -
Mi QUIT CARE (Mile Square QUIT Community-Access-Referral-Expansion)
|
N/A | |
Completed |
NCT05560243 -
Tobacco Cessation Tailored to Patients Living With HIV (PLWH) in Brazil
|
N/A | |
Completed |
NCT02721082 -
Changing the Default for Tobacco Treatment
|
Phase 4 | |
Completed |
NCT01885221 -
A Multi-Media Approach to Partner Support in Smokeless Tobacco Cessation (UCare-ChewFree)
|
N/A | |
Completed |
NCT03445507 -
Effectiveness of a Chat Bot for Smoking Cessation: a Pragmatic Trial in Primary Care.
|
N/A | |
Completed |
NCT04540081 -
Enhancing Electronic Health Systems to Decrease the Burden of Colon Cancer, Lung Cancer, Obesity, Vaccine-Preventable Illness, and LivER Cancer
|
N/A | |
Completed |
NCT03714191 -
Optimizing the Tobacco Cessation Clinical Decision Support Tool.
|
||
Completed |
NCT03553992 -
An Extended Facebook Intervention for Young Sexual and Gender Minority Smokers
|
N/A | |
Completed |
NCT01699828 -
Exploring Occupancy of Dopamine D3 Receptor by Buspirone in Humans Using PET
|
Phase 1/Phase 2 |